The association of cannabis with the reduction of developmental colorectal cancer
Case studies suggest that there is an anti-inflammatory agent in cannabis.
One study found a link between cannabis use and a lower risk of colon cancer, anaemia and hospitalisation.
The nationwide inpatient sample data sets (2010-2014) were examined to identify adults with crohn’s disease (CD) and ulcerative colitis (UC).
Recent studies about Crohn’s disease and Cannabis
This is the result of a study conducted by Atlanta VA Medical Center in Decatur, USA:
The study examined 6,002 patients with CD (2,999 cannabis users & 3,003 non-users) and 1,481 patients with UC (742 cannabis users & 739 non-users).
In patients with CD, the presence of colorectal cancer, the need for parenteral nutrition, and anemia were lower in cannabis users.
However, active fistula disease or intra-abdominal abscess formation, non-specific bleeding in the lower gastrointestinal tract and hypovolemia were higher in recreational cannabis use.
Additionally, the average hospital stay was shorter with lower hospital costs among cannabis users.